These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27158847)

  • 21. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
    Schmid P; Bregenzer A; Huber M; Rauch A; Jochum W; Müllhaupt B; Vernazza P; Opravil M; Weber R;
    PLoS One; 2015; 10(9):e0138838. PubMed ID: 26418061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection.
    Sullivan LE; Goulet JL; Justice AC; Fiellin DA
    Drug Alcohol Depend; 2011 Sep; 117(2-3):158-63. PubMed ID: 21345624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
    Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
    J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol Types and HIV Disease Progression Among HIV-Infected Drinkers Not Yet on Antiretroviral Therapy in Russia and Uganda.
    Asiimwe SB; Fatch R; Patts G; Winter M; Lloyd-Travaglini C; Emenyonu N; Muyindike W; Kekibiina A; Blokhina E; Gnatienko N; Kruptisky E; Cheng DM; Samet JH; Hahn JA
    AIDS Behav; 2017 Nov; 21(Suppl 2):204-215. PubMed ID: 28856539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index.
    Suh B; Yun JM; Park S; Shin DW; Lee TH; Yang HK; Ahn E; Lee H; Park JH; Cho B
    Cancer; 2015 Nov; 121(21):3818-25. PubMed ID: 26178294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
    Mehta SH; Thomas DL; Torbenson M; Brinkley S; Mirel L; Chaisson RE; Moore RD; Sulkowski MS
    Hepatology; 2005 Jan; 41(1):123-31. PubMed ID: 15619237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.
    Provoost A; Dramé M; Cotte L; Cuzin L; Garraffo R; Rey D; Raffi F; Poizot-Martin I; Pugliese P; Bani-Sadr F;
    Aliment Pharmacol Ther; 2018 Aug; 48(3):281-289. PubMed ID: 29901821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.
    Marcellin F; Roux P; Loko MA; Lions C; Caumont-Prim A; Dabis F; Salmon-Ceron D; Spire B; Carrieri MP;
    Clin Infect Dis; 2014 Oct; 59(8):1190-2. PubMed ID: 25015913
    [No Abstract]   [Full Text] [Related]  

  • 29. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.
    Fuster D; Tsui JI; Cheng DM; Quinn EK; Armah KA; Nunes D; Freiberg MS; Samet JH
    AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1110-6. PubMed ID: 23601055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis.
    Chang Y; Ryu S; Kim Y; Cho YK; Sung E; Kim HN; Ahn J; Jung HS; Yun KE; Kim S; Sung KC; Sohn CI; Shin H; Wild SH; Byrne CD
    Hepatology; 2020 Mar; 71(3):861-873. PubMed ID: 31325180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.
    Ding Y; Duan S; Ye R; Yang Y; Yao S; Wang J; Cao D; Liu X; Lu L; Jia M; Wu Z; He N
    J Viral Hepat; 2017 May; 24(5):412-420. PubMed ID: 27925409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
    Neukam K; Mira JA; Ruiz-Morales J; Rivero A; Collado A; Torres-Cornejo A; Merino D; de Los Santos-Gil I; Macías J; González-Serrano M; Camacho A; Parra-García G; Pineda JA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2605-14. PubMed ID: 21903660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
    Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
    Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B;
    AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies.
    Trickey A; Ingle SM; Boyd A; Gill MJ; Grabar S; Jarrin I; Obel N; Touloumi G; Zangerle R; Rauch A; Rentsch CT; Satre DD; Silverberg MJ; Bonnet F; Guest J; Burkholder G; Crane H; Teira R; Berenguer J; Wyen C; Abgrall S; Hessamfar M; Reiss P; d'Arminio Monforte A; McGinnis KA; Sterne JAC; Wittkop L;
    J Viral Hepat; 2023 Sep; 30(9):775-786. PubMed ID: 37338017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study.
    Gordon SC; Lamerato LE; Rupp LB; Holmberg SD; Moorman AC; Spradling PR; Teshale E; Xu F; Boscarino JA; Vijayadeva V; Schmidt MA; Oja-Tebbe N; Lu M
    Am J Gastroenterol; 2015 Aug; 110(8):1169-77; quiz 1178. PubMed ID: 26215529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients.
    Tural C; Fuster D; Tor J; Ojanguren I; Sirera G; Ballesteros A; Lasanta JA; Planas R; Rey-Joly C; Clotet B
    J Viral Hepat; 2003 Mar; 10(2):118-25. PubMed ID: 12614468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons.
    Brunet L; Moodie EEM; Young J; Cox J; Hull M; Cooper C; Walmsley S; Martel-Laferrière V; Rachlis A; Klein MB; ; Cohen J; Conway B; Cooper C; Côté P; Cox J; Gill J; Haider S; Sadr A; Johnston L; Hull M; Montaner J; Moodie E; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall JM; Vachon ML; Sanche S; Skinner S; Wong D
    Clin Infect Dis; 2016 Jan; 62(2):242-249. PubMed ID: 26400998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
    Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
    PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.